Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
This study has been completed.
Study NCT00001444   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Lymphoma
Neoplasm
Prostatic Neoplasm
Additional conditions recognized in this trial
Breast Neoplasms
Neoplasms
Prostatic Neoplasms
More general conditions related to this trial
Breast Diseases
Genital Diseases, Male
Genital Neoplasms, Male
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Prostatic Diseases
Skin Diseases
Urogenital Neoplasms
Interventions listed in this trial
7-hydroxystaurosporine (UCN-01)
Additional drug interventions recognized in this trial
7-hydroxystaurosporine
Staurosporine
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services